These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8877080)

  • 1. Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial.
    Wiklund I; Waagstein F; Swedberg K; Hjalmarsson A
    Cardiovasc Drugs Ther; 1996 Jul; 10(3):361-8. PubMed ID: 8877080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
    Waagstein F; Bristow MR; Swedberg K; Camerini F; Fowler MB; Silver MA; Gilbert EM; Johnson MR; Goss FG; Hjalmarson A
    Lancet; 1993 Dec; 342(8885):1441-6. PubMed ID: 7902479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial. The Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
    Lancet; 1998 Apr; 351(9110):1180-1. PubMed ID: 9643698
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy.
    Currie PJ; Kelly MJ; McKenzie A; Harper RW; Lim YL; Federman J; Anderson ST; Pitt A
    J Am Coll Cardiol; 1984 Jan; 3(1):203-9. PubMed ID: 6140277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
    Waagstein F; Strömblad O; Andersson B; Böhm M; Darius M; Delius W; Goss F; Osterziel KJ; Sigmund M; Trenkwalder SP; Wahlqvist I
    Eur J Heart Fail; 2003 Oct; 5(5):679-91. PubMed ID: 14607208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.
    De Maria R; Di Lenarda A; Gavazzi A; Porcu M; Sinagra G; Parolini M;
    Ital Heart J; 2001 Feb; 2(2):130-8. PubMed ID: 11256541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
    Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
    N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of beta-blockers in left ventricular dysfunction and heart failure.
    Hjalmarson A; Kneider M; Waagstein F
    Drugs; 1997 Oct; 54(4):501-10. PubMed ID: 9339958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study.
    Eichhorn EJ; Heesch CM; Barnett JH; Alvarez LG; Fass SM; Grayburn PA; Hatfield BA; Marcoux LG; Malloy CR
    J Am Coll Cardiol; 1994 Nov; 24(5):1310-20. PubMed ID: 7930255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
    Di Lenarda A; Sabbadini G; Salvatore L; Sinagra G; Mestroni L; Pinamonti B; Gregori D; Ciani F; Muzzi A; Klugmann S; Camerini F
    J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
    G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival effect of metoprolol in dilated cardiomyopathy. The SPIC (Italian Multicentre Cardiomyopathy Study) Group.
    Di Lenarda A; De Maria R; Gavazzi A; Gregori D; Parolini M; Sinagra G; Salvatore L; Longaro F; Bernobich E; Camerini F
    Heart; 1998 Apr; 79(4):337-44. PubMed ID: 9616339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience.
    Shaddy RE; Tani LY; Gidding SS; Pahl E; Orsmond GS; Gilbert EM; Lemes V
    J Heart Lung Transplant; 1999 Mar; 18(3):269-74. PubMed ID: 10328154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of race in the response to metoprolol in patients with congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.
    Freudenberger R; Kalman J; Mannino M; Buchholz-Varley C; Ocampo O; Kukin M
    Am J Cardiol; 1997 Nov; 80(10):1372-4. PubMed ID: 9388121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated cardiomyopathy.
    Clements IP; Miller WL
    Am Heart J; 2001 Feb; 141(2):259. PubMed ID: 11174349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.
    Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Matsunaka T; Suzuki J; Shigematsu Y
    Heart Vessels; 2002 Dec; 17(2):53-6. PubMed ID: 12541094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.
    Engelmeier RS; O'Connell JB; Walsh R; Rad N; Scanlon PJ; Gunnar RM
    Circulation; 1985 Sep; 72(3):536-46. PubMed ID: 3893793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beta-adrenergic blocking therapy on left ventricular diastolic relaxation properties in patients with dilated cardiomyopathy.
    Kim MH; Devlin WH; Das SK; Petrusha J; Montgomery D; Starling MR
    Circulation; 1999 Aug; 100(7):729-35. PubMed ID: 10449695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of beta-blockers in the treatment of cardiomyopathy and ischaemic heart failure.
    Hjalmarson A; Waagstein F
    Drugs; 1994; 47 Suppl 4():31-9; discussion 39-40. PubMed ID: 7523060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study.
    Circulation; 2000 Feb; 101(4):378-84. PubMed ID: 10653828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.